HUM-MOLGEN archive: ETHI: 2 messages

Subj: ETHI: Development of Bioethics Curriulum From: Michael Rossi <rossimj@CHARGER.NEWHAVEN.EDU> I am trying to add a bioethics component to a graduate cellular and molecular biology program. I need advice on ways in which to do this. It would be preferable to have this component be developed with in the context of existing courses, but our past attempts have not been as successful as I would have hoped. I would welcome comments from anyone with insight into this issue. Michael Rossi University of New Haven rossimj@charger.newhaven.edu EDITOR's NOTE: Perhaps somebody who has developed such a curriculum could post it to HUM-MOLGEN web site or to the list. The Kennedy Bioethics Institute has published a series of scope notes on most of the important issues: they are available on the web and would seem to be a suitable starting point for a formal curriculum at any level.-HG ***************************************************************************** ********* RE: ETHI, MUTIPLEX SCREENING 27-NOV-1995 10:48:20.92 From: Gary Swergold <swergold@BOX-S.NIH.GOV> There is a very simple and important need for multiplex genetic screening that has so far gone un-noticed here. The cost of screeening for rare disorders is very high, partly because each test must be run separately. Inother words, there is a set up cost for every test whether one is doing one test or 50 tests. If one could combine the tests for 50 people, each with a separate rare disorder, the set up cost for each of them would go down and the cost of testing for rare disorders would become more economical. Gary Swergold M.D., Ph.D. Food & Drug Administration Center for Biologics Evaluation & Research Division of Cell & Gene Therapy Regulation HFM 515 1401 Rockville Pike Rockville, Maryland 20852-1448 V: (301)827-0667 F: (301)480-3351 EMail: swergold@box-s.nih.gov